1. L. K. Dil’mukhametova, T. S. Pronina, G. Z. Ziyazetdinova, et al., “The role of noradrenaline in the development of dopamine-dependent hyperprolactinemia,” Neirokhimiya, 26, No. 4, 318–327 (2009).
2. G. Z. Ziyazetdinova, A. Ya. Sapronova, V. Ya. Kiyasova, et al., “Compensatory reaction in degeneration of dopaminergic neurons in the arcuate nucleus,” Zh. Evolyuts. Biokhim. Fiziol., 44, No. 1, 72–77 (2008).
3. M. A. Abramova, A. Calas, and M. Ugrumov, “Vasopressinergic neurons of the supraoptic nucleus in perinatal rats: reaction to osmotic stimulation and its regulation,” Brain Structure Function, 215, No. 3–4, 195–207 (2011).
4. N. Ben-Jonathan and R. Hnasko, “Dopamine as a prolactin (PRL) inhibitor,” Endocrine Rev., 22, No. 6, 724–763 (2001).
5. F. Blandini, M. T. Armentero, and E. Martignoni, “The 6-hydroxydopamine model: news from the past,” Parkinsonism Related Disorders, 14, No. 2, S124–S129 (2008).